In many tumor types, including NSCLC, PD-L1 expression is observed in tumor cells, especially in poorly differentiated tumors, and several large meta-analyses have shown that increased PD-L1 expression has a negative prognostic impact [253, 254]. This evidence concerns the gene CD274 and neoplasm.